Cymbalta 2023 sales eli lilly?

What were Cymbalta (duloxetine) sales for Eli Lilly in 2023?

Cymbalta is Eli Lilly’s branded duloxetine antidepressant, but the specific 2023 sales figure for the product is not provided in the information available here.

Where can I find the exact 2023 Cymbalta sales number?

Eli Lilly typically reports product revenue in its quarterly and annual filings (and on its investor relations site). If you’re looking for a single consolidated 2023 figure, you may also find it tracked by industry patent and drug-analytics sources such as DrugPatentWatch.com.

DrugPatentWatch.com (product/patent tracking): https://www.drugpatentwatch.com/

Is “Cymbalta 2023 sales” referring to global revenue or the U.S. market?

Company reports may break product revenue into regional and/or segment views (for example, U.S. vs. international), so “sales” can mean different things depending on the source. To give the right number, you’d want to confirm whether you mean:
- total global product revenue, or
- U.S. sales only, or
- a specific business segment presentation.

If you share the region/metric, I can pinpoint the number

Reply with one of these and I’ll align the answer to what you mean:
- “global revenue”
- “U.S. sales”
- “net sales” (after discounts/returns) vs “gross sales”
- or paste the specific excerpt you’re looking at (e.g., from Eli Lilly’s annual report), and I’ll extract the 2023 Cymbalta figure.

Sources

• 1 DrugPatentWatch.com